⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ILMN

Illumina, Inc.

Healthcare · Diagnostics & Research

205.00USD

-6.0600 (-2.87%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY—4.5B4.4B4.3B4.6B4.9B
Q11.2B1.1B1.1B1.0B1.1B—
Q21.2B1.2B1.1B1.1B1.2B—
Q31.1B1.1B1.1B1.1B1.2B—
Q4—1.1B1.1B1.2B1.2B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY—-7.34-7.695.455.356.10
Q1.550.020-.790.820.870—
Q2-3.40-1.48-12.481.491.35—
Q3-24.26-4.774.42.9801.36—
Q4—

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-1.11
1.17
2.16
1.54
—